SCHEMBL9728652

SCHEMBL9728652

O=C(Cc1ccccc1)C(=O)Nc1ccc(Cc2ccccc2-n2ccnc2)cc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.41
PKM P14618 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDE5A O76074 2/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CYP3A4 P08684 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
SLC22A8 Q8TCC7 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
WNT3A P56704 1/20 0.36
GRIK1 P39086 1/20 0.36
GRIA1 P42261 1/20 0.36
GRIA2 P42262 1/20 0.36
GRIA3 P42263 1/20 0.36
GRIA4 P48058 1/20 0.36
GRIK2 Q13002 1/20 0.36
GRIK3 Q13003 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10580662 0.88 HTT (0.42) CYP19A1PKMMAPTNPC1RAB9A
SCHEMBL10581971 0.85 GRIK1 (0.41) CYP19A1PDE5AMAPTNPC1RAB9A
SCHEMBL9663819 0.81 CYP19A1 (0.42) CYP19A1MAPTNPC1RAB9ASLC22A6
SCHEMBL9728182 0.81 CYP19A1 (0.59) CYP19A1PKML3MBTL1MAPTCYP3A4
SCHEMBL10579885 0.79 MAPT (0.42) PKML3MBTL1PDE5AMAPTMEN1
SCHEMBL9191692 0.78 CYP19A1 (0.43) CYP19A1PDE5AMAPTCYP3A4MEN1
SCHEMBL9198511 0.76 CYP19A1 (0.39) CYP19A1MAPTNPC1RAB9ACYP3A4
SCHEMBL9197258 0.76 CYP1A2 (0.41) CYP19A1CYP3A4GRIK1GRIA1GRIA2
SCHEMBL9728310 0.75 CYP26A1 (0.45) CYP19A1PKML3MBTL1MAPTNPC1
SCHEMBL9759953 0.75 IDO1 (0.41) L3MBTL1CYP3A4MEN1KMT2AWNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed